Clinical Trial Update: Early Vascular Healing in Acute Coronary Syndrome Patients With Different Doses of Rosuvastatin [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating early vascular healing in acute coronary syndrome patients treated with different doses of rosuvastatin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN